Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.1 (
protein kinase
)
81,284
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
EL2
gene of rice (Oryza sativa), previously classified as early response gene against the potent biotic elicitor N-acetylchitoheptaose and encoding a short polypeptide with unknown function, was identified as a novel cell cycle regulatory gene related to the recently reported SIAMESE (SIM) gene of Arabidopsis thaliana. Iterative two-hybrid screens, in vitro pull-down assays, and fluorescence resonance energy transfer analyses showed that Orysa;
EL2
binds the
cyclin-dependent kinase
(
CDK
) CDKA1;1 and D-type cyclins. No interaction was observed with the plant-specific B-type CDKs. The amino acid motif ELERFL was identified to be essential for cyclin, but not for
CDK
binding. Orysa;
EL2
impaired the ability of Orysa; CYCD5;3 to complement a budding yeast (Saccharomyces cerevisiae) triple CLN mutant, whereas recombinant protein inhibited
CDK
activity in vitro. Moreover, Orysa;
EL2
was able to rescue the multicellular trichome phenotype of sim mutants of Arabidopsis, unequivocally demonstrating that Orysa;
EL2
operates as a cell cycle inhibitor. Orysa;
EL2
mRNA levels were induced by cold, drought, and propionic acid. Our data suggest that Orysa;
EL2
encodes a new type of plant
CDK
inhibitor that links cell cycle progression with biotic and abiotic stress responses.
...
PMID:Novel plant-specific cyclin-dependent kinase inhibitors induced by biotic and abiotic stresses. 1759 8